Tetrapeptide Compositions for Treating Eye Disorders
Summary
The USPTO granted patent US12605422B2 to S.I.S SHULOV INNOVATIVE SCIENCE LTD. on April 21, 2026, covering tetrapeptide pharmaceutical compositions for treating degenerative, age-related, and trauma-induced disorders of the eye. The patent, application number 17762984, was filed September 23, 2020, and contains 20 claims classified under CPC codes A61K 38/07, A61P 25/28, and C07K 5/1024.
What changed
USPTO granted patent US12605422B2 to S.I.S SHULOV INNOVATIVE SCIENCE LTD. for pharmaceutical compositions comprising specific tetrapeptides for use in treating, preventing, minimizing, diminishing or reversing degenerative, age-related, and trauma-induced disorders, particularly of the eye.
Pharmaceutical and biotechnology companies developing peptide-based therapeutics for ophthalmic conditions should review this patent to assess potential freedom-to-operate implications. The tetrapeptide compositions covered by the 20 granted claims represent enforceable intellectual property that may affect R&D programs targeting similar eye disorder treatments.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Compositions and methods for treating degenerative, age-related and trauma-induced disorders
Grant US12605422B2 Kind: B2 Apr 21, 2026
Assignee
S.I.S SHULOV INNOVATIVE SCIENCE LTD.
Inventors
Naftali Primor
Abstract
Pharmaceutical compositions comprising specific tetrapeptides, for use in treating, preventing, minimizing, diminishing or reversing degenerative, age-related and trauma-induced disorders, particularly of the eye, are provided.
CPC Classifications
A61K 38/07 A61P 25/28 C07K 5/1024
Filing Date
2020-09-23
Application No.
17762984
Claims
20
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.